|
RPL29 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62525548574877E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67232894199287E-12 |
| Normal-vs-Stage2 |
1.240500E-03 |
| Normal-vs-Stage3 |
1.7318399999966E-05 |
| Normal-vs-Stage4 |
3.845100E-04 |
| Stage1-vs-Stage2 |
8.630400E-01 |
| Stage1-vs-Stage3 |
8.380800E-01 |
| Stage1-vs-Stage4 |
4.630900E-04 |
| Stage2-vs-Stage3 |
7.866200E-01 |
| Stage2-vs-Stage4 |
1.190180E-02 |
| Stage3-vs-Stage4 |
7.657800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.69089999779715E-08 |
| Normal-vs-Asian |
6.565800E-02 |
| Caucasian-vs-AfricanAmerican |
1.475430E-01 |
| Caucasian-vs-Asian |
7.629200E-01 |
| AfricanAmerican-vs-Asian |
8.235600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.88098491916389E-15 |
| Normal-vs-Female |
8.89129880832229E-11 |
| Male-vs-Female |
1.944770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.24850000005061E-07 |
| Normal-vs-Extreme_Weight |
8.11573031000989E-14 |
| Normal-vs-Obese |
3.08320002861961E-09 |
| Normal-vs-Extreme_Obese |
4.344300E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.983200E-01 |
| Normal_Weight-vs-Obese |
2.494400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.233800E-01 |
| Extreme_Weight-vs-Obese |
8.157800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.974200E-01 |
| Obese-vs-Extreme_Obese |
9.164600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.09139999999275E-05 |
| Normal-vs-Age(41-60Yrs) |
6.20070661483396E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6983081607691E-12 |
| Normal-vs-Age(81-100Yrs) |
3.042700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.318300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.287900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.117000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.176000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.416600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.994800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63635771599502E-12 |
| Normal-VS-Type2 PRCC |
7.6305999963111E-08 |
| Normal-VS-KIRP CIMP |
1.62436730732907E-12 |
| Normal-VS-Unclassified PRCC |
2.45320000002991E-06 |
| Type1 PRCC-VS-Type2 PRCC |
9.734200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.19019999972525E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
8.400400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.29070000243203E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
3.298800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.36920000002061E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0414999995767E-07 |
| Normal-vs-N1 |
4.77369999996036E-06 |
| Normal-vs-N2 |
3.735600E-02 |
| N0-vs-N1 |
7.209800E-02 |
| N0-vs-N2 |
3.699600E-02 |
| N1-vs-N2 |
3.387800E-01 |
|
|
